Schedule 13G ownership disclosure

UROGEN PHARMA LTD

Security class unavailable · CUSIP: M96088105

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,840,637
Percent of class
8.3300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-21-000042
Form type
SC 13G/A
Filer
UroGen Pharma Ltd.
CIK
CIK 1668243
Filed
Feb 03, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub